Science Communications & Media Relations Manager @UCLAHealthJCCC. Big sweet tooth. Breakfast person. Swiftie. Views are my own.
Los Angeles, CA
Joined September 2009
- Tweets2.3K
- Following1.2K
- Followers620
- Likes6K
Denise Heady retweeted
Congratulations to Dr. Dennis Slamon, recipient of the 2026 Albany Prize for groundbreaking discoveries that transformed how we understand and treat cancer. An incredible and well-deserved honor!
bit.ly/4rTVB3k
Denise Heady retweeted
True privilege to share, with the patient himself as a key coauthor, this Virtual Tumor Board in @CACancerJournal describing treatment of recurrent/metastatic prostate cancer over a series of IITs, leading to no evidence of disease for now over 3 years. @UCLAHealthJCCC
New #VirtualTumorBoard presents a patient with recurrent #ProstateCancer after radical prostatectomy, covering biochemical recurrence to metastatic disease.
🔗: acsjournals.onlinelibrary.wi…
@OncoAlert @AmarUKishan @omgitsyuliaz @KekoaMDPhD @MSteinbergMD @CalaisJeremie #PCAM
Denise Heady retweeted
A study led by @DrNimmiKapoor suggests that breast cancers diagnosed within the first three years after childbirth may be biologically more aggressive, highlighting the importance of reproductive history when evaluating young women with breast cancer.
bit.ly/4f3FM3N
Denise Heady retweeted
New UCLA-led study published in @JAMAOnc found that changing the terminology of the lowest-risk prostate cancer to precancerous could dramatically reduce overtreatment and save lives.
bit.ly/4wk9Xe6
Denise Heady retweeted
A more precise approach to ovarian cancer treatment is now being tested at UCLA. Two clinical trials are evaluating antibody-drug conjugates, targeted therapies that deliver chemotherapy directly to cancer cells while potentially reducing side effects.
bit.ly/4vtyBZg
Denise Heady retweeted
Grateful to have sat down with the @breastcancerorg team at #ASCO2026 to talk about something close to my heart. In this episode, I share my own breast cancer journey, why I founded Tómatelo a Pecho and the work we do for women's health, and why I believe cancer control can be a powerful driver for creating better, more equitable healthcare systems worldwide.
Full episode here: breastcancer.org/podcast/can…
#BreastCancer #BreastCancerAwareness #WomensHealth #TómatéloAPecho
Denise Heady retweeted
Honored to have spoken on the main stage at ASCO 2026 today alongside Chancellor Julio Frenk on expanding global access to cancer care. Grateful for the platform and the shared commitment to transforming cancer care worldwide.
#ASCO2026 #BreastCancer #HealthEquity #GlobalOncology #PatientAdvocacy
Denise Heady retweeted
"It’s one of the most emotional studies I’ve ever been a part of."
- Dr. Zev Wainberg on a clinical trial that found a new investigational targeted therapy doubled survival in metastatic pancreatic cancer.
Excitement for the new drug daxaronrasib is spilling over to other types of cancer. It works by targeting a mutation in the KRAS gene found across many cancers, including lung, colorectal, ovarian, endometrial and a type of bile duct cancer. nbcnews.com/health/health-ne…
Such a great intro by @erikaedwardsnbc to an incredible story about a new drug that was found to double the survival in patients with pancreatic cancer. #ASCO26
nbcnews.com/health/health-ne…
Denise Heady retweeted
In this Q&A, Dr. Benjamin Ellingson discusses how advanced imaging is helping researchers better understand glioblastoma and develop more personalized treatments. @RadiologyUcla
Learn more: bit.ly/4v4hbm3
Denise Heady retweeted
May is #BrainCancerAwarenessMonth. At @UCLAHealth, Dr. David Nathanson is advancing new therapies for glioblastoma by targeting the tumor’s unique biology, with the goal of overcoming some of the disease’s toughest treatment challenges.
bit.ly/3QMHRcf
Denise Heady retweeted
Meet some of the UCLA experts turning research into real-world impact. #ResearchPowersProgress
ucla.edu/research
A looping carousel pairs UCLA faculty portraits with a prompt highlighting their impact and a simple descriptor of their expertise.
Denise Heady retweeted
New research in @CD_AACR led by @CampKatiee & Dr. Antoni Ribas suggests tumor structure, not just genetics, could eventually help guide melanoma treatment decisions & identify patients most likely to benefit from combination immunotherapy.
bit.ly/3QU0lY0
Denise Heady retweeted
UCLA researchers develop low-cost blood test capable of detecting multiple cancers from a single sample. newsroom.ucla.edu/releases/u…
Denise Heady retweeted
Congrats to Dr. Antoni Ribas on receiving the @AACR Margaret Foti Award for Leadership & Extraordinary Achievements in Cancer Research. A pioneer in cancer immunotherapy, his work has transformed outcomes for patients with advanced melanoma & beyond.
bit.ly/4ch62qk
Denise Heady retweeted
UCLA & @parkerici collaborators engineered “supercharged” T cells that latch onto prostate cancer like a fishhook, making them stronger, longer lasting & more precise. Findings can lead to safer, more effective T cell therapies for prostate cancer.
bit.ly/4cZcbte
Denise Heady retweeted
UCLA gastroenterologist Folasade May discusses rising colorectal cancer rates among young adults and a public awareness display at UCLA. newsroom.ucla.edu/in-the-new…
Denise Heady retweeted
A new UCLA study published in @JAMANetworkOpen found that a personalized counseling program can significantly help women who have survived cervical precancer or cervical cancer to quit smoking.
bit.ly/4b7rzlW
Thanks @ABC7 for covering this important event and helping raise awareness about the rising risk of colorectal cancer in people under 50.
Giant inflatable colon display at UCLA highlights rising colorectal cancer risk in young adults spr.ly/6014B686ZY
Denise Heady retweeted
New study published today in @TheLancet & presented at #ASCOGU26 by @AmarUKishan found that adding hormone therapy to post-operative radiotherapy may provide little survival benefit for most men with prostate cancer.
bit.ly/3ZYBN1u
